Background illustration for clinical trials search

Paid Clinical Trials California

Discover 5,800 paid clinical trials in California. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

Open Label Study for the Use of Low Intensity Focused Ultrasound for Essential Tremor

for
Essential Tremor
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18 - 70+

Code: NCT07599592

Early Phase 1, Recruiting
Active & Responsive

A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis

for
Secondary AML, Myelofibrosis
Location: San Diego CA, Duarte CA, Sacramento CA
Sponsor: Aspera Biomedicines, Inc.

Sex: All

Age: 18+

Code: NCT07250646

Phase 1, Recruiting
Active & Responsive

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

for
Solid Tumors
Location: St. Petersburg FL, Germantown TN, Rochester MN,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07415031

Phase 2, Recruiting
Active & Responsive

A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade

for
Fentanyl Overdose, Fentanyl Poisoning
Location: Glendale CA
Sponsor: Clear Scientific, Inc.

Sex: All

Age: 18 - 55

Code: NCT07459166

Phase 2, Recruiting
Active & Responsive

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

for
Non-small Cell Lung Cancer
Location: New Haven CT, White Plains NY, Albany NY, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07513376

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease

for
Late-onset Pompe Disease
Location: Fairfax VA, Durham NC, St Louis MO, Irvine CA
Sponsor: Denali Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT07354724

Phase 1, Recruiting
Active & Responsive

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

for
Castration Resistant Metastatic Prostate Cancer,
Location: Boston MA, Miami FL, Pittsburgh PA, Grand Rapids MI,
Sponsor: Aktis Oncology, Inc.

Sex: Male

Age: 18+

Code: NCT07581184

Phase 1, Recruiting
Active & Responsive

Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment

for
Dry Eye, Meibomian Gland Dysfunction
Location: Berkeley CA
Sponsor: University of California, Berkeley

Sex: All

Age: 18+

Code: NCT07606625

Recruiting
Active & Responsive

Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial

for
Myopia
Location: Boston MA, New York NY, Elkins Park PA, Columbus OH,
Sponsor: Ohio State University

Sex: All

Age: 6 - 11

Code: NCT07567040

Phase 3, Recruiting
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Portland ME, Waterford CT, Manchester CT,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07496567

Phase 2, Phase 3, Recruiting
Active & Responsive

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

for
Primary Immune Thrombocytopenia (ITP),
Location: New Haven CT, Stamford CT, The Bronx NY, Summit NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07421167

Phase 2, Recruiting
Active & Responsive

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

for
HR+ HER2- Breast Cancer
Location: Nashville TN, Austin TX, San Antonio TX, Lone Tree CO,
Sponsor: Faeth Therapeutics

Sex: All

Age: 18+

Code: NCT07558733

Phase 1, Phase 2, Recruiting
Active & Responsive

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

for
Urothelial Carcinoma
Location: New York NY, Toronto, Pittsburgh PA, Cleveland OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05562830

Phase 1, Phase 2, Recruiting
Active & Responsive

A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

for
High-Risk Neuroblastoma
Location: The Bronx NY, Philadelphia PA, Durham NC, Toronto,
Sponsor: Renaissance Pharma Ltd.

Sex: All

Age: 1 - 18

Code: NCT07549321

Phase 2, Phase 3, Recruiting
Active & Responsive

FACE Phase II (a Stage II Trial)

for
MCI, Subjective Cognitive Decline (SCD),
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 60 - 70+

Code: NCT07130669

Phase 1, Phase 2, Recruiting
Active & Responsive

Bladder EpiCheck Product Development Study

for
Suspicion of Bladder Cancer, NMIBC Surveillance
Location: Towson MD, San Diego CA
Sponsor: Nucleix Ltd.

Sex: All

Age: 22+

Code: NCT07514143

Recruiting
Active & Responsive

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

for
Multiple Myeloma in Relapse, Myeloma Multiple,
Location: Boston MA, Hackensack NJ, Tampa FL, Atlanta GA,
Sponsor: Kelonia Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07075185

Phase 1, Recruiting
Active & Responsive

A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study

for
Patient-Reported Outcome Measures (PROMs), Pragmatic Trial,
Location: Boston MA, New York NY, Philadelphia PA, Charleston SC,
Sponsor: Carelon Research

Sex: All

Age: 12 - 17

Code: NCT07525843

Recruiting
Active & Responsive

A Study of TAK-505 in Adults With Solid Tumors

for
Malignant Solid Tumors
Location: New York NY, Fairfax VA, Tampa FL, Cleveland OH,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07436728

Phase 1, Phase 2, Recruiting
Active & Responsive

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

for
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,
Location: Boston MA, Atlanta GA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18 - 70+

Code: NCT07020533

Phase 1, Recruiting

Popular cities in California

With its extensive healthcare system and world-class medical research institutions, California is a major hub for clinical trials. Leading research centers such as UCLA Health, Stanford Medicine, the University of California, the City of Hope, San Francisco (UCSF), and the Scripps Research Institute are spearheading medical research and innovation. These institutions are at the cutting edge of clinical studies, driving advancements in groundbreaking treatments and significantly contributing to healthcare innovations across the state.

Why choose California for clinical trials?

The state of California offers a variety of benefits for participants in clinical trials. Firstly, because the state is home to leading research institutions, it provides participants with access to cutting-edge treatments and advanced medical technologies before they become widely available. These institutions are equipped with state-of-the-art facilities and staffed by top experts, ensuring high-quality care and rigorous monitoring throughout the study.

California's diverse and innovative research landscape offers a wide range of study options, enhancing the likelihood of finding a trial that matches specific health needs. Moreover, the state's adherence to stringent regulatory and ethical standards ensures that trials are conducted with the utmost integrity and participant protection.

Common conditions studied in California

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in California